EA201000397A1 - Новый способ синтеза ивабрадина и его солей присоединения с фармацевтически приемлемой кислотой - Google Patents
Новый способ синтеза ивабрадина и его солей присоединения с фармацевтически приемлемой кислотойInfo
- Publication number
- EA201000397A1 EA201000397A1 EA201000397A EA201000397A EA201000397A1 EA 201000397 A1 EA201000397 A1 EA 201000397A1 EA 201000397 A EA201000397 A EA 201000397A EA 201000397 A EA201000397 A EA 201000397A EA 201000397 A1 EA201000397 A1 EA 201000397A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- synthesis
- salts
- ivabradin
- connection
- new method
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Heart & Thoracic Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Способ синтеза ивабрадина формулы (I)и его солей присоединения с фармацевтически приемлемой кислотой.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0901555A FR2943667B1 (fr) | 2009-03-31 | 2009-03-31 | Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable. |
Publications (2)
Publication Number | Publication Date |
---|---|
EA201000397A1 true EA201000397A1 (ru) | 2010-12-30 |
EA016335B1 EA016335B1 (ru) | 2012-04-30 |
Family
ID=40984744
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201000397A EA016335B1 (ru) | 2009-03-31 | 2010-03-30 | Новый способ синтеза ивабрадина и его солей присоединения с фармацевтически приемлемой кислотой |
Country Status (37)
Country | Link |
---|---|
US (1) | US8101747B2 (ru) |
EP (1) | EP2241554B1 (ru) |
JP (1) | JP5107382B2 (ru) |
KR (1) | KR101166630B1 (ru) |
CN (2) | CN102603634B (ru) |
AR (1) | AR075977A1 (ru) |
AT (1) | ATE523494T1 (ru) |
AU (1) | AU2010201058B2 (ru) |
BR (1) | BRPI1000735A2 (ru) |
CA (1) | CA2697562C (ru) |
CL (1) | CL2010000254A1 (ru) |
CY (1) | CY1112136T1 (ru) |
DK (1) | DK2241554T3 (ru) |
EA (1) | EA016335B1 (ru) |
ES (1) | ES2373369T3 (ru) |
FR (1) | FR2943667B1 (ru) |
GE (1) | GEP20125460B (ru) |
HK (2) | HK1148748A1 (ru) |
HR (1) | HRP20110915T1 (ru) |
JO (1) | JO2782B1 (ru) |
MA (1) | MA31745B1 (ru) |
ME (1) | ME00987B (ru) |
MX (1) | MX2010003184A (ru) |
MY (1) | MY145611A (ru) |
NZ (1) | NZ584309A (ru) |
PE (1) | PE20100714A1 (ru) |
PL (1) | PL2241554T3 (ru) |
PT (1) | PT2241554E (ru) |
RS (1) | RS51962B (ru) |
SA (1) | SA110310240B1 (ru) |
SG (1) | SG165254A1 (ru) |
SI (1) | SI2241554T1 (ru) |
TW (1) | TWI419879B (ru) |
UA (1) | UA102232C2 (ru) |
UY (1) | UY32500A (ru) |
WO (1) | WO2010112704A1 (ru) |
ZA (1) | ZA201002121B (ru) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT2471780E (pt) * | 2007-05-30 | 2015-02-24 | Ind Swift Lab Ltd | Sais oxalato de ivabradina cristalinos e seus polimorfos |
CN103848789B (zh) * | 2012-11-29 | 2016-05-18 | 江苏恒瑞医药股份有限公司 | 一种伊伐布雷定的制备方法 |
CN103724266B (zh) * | 2014-01-20 | 2018-12-04 | 山东诚创医药技术开发有限公司 | 去甲伊伐布雷定盐及其制备方法和应用 |
EP3101010A1 (en) | 2015-06-03 | 2016-12-07 | Urquima S.A. | New method for the preparation of highly pure ivabradine base and salts thereof |
CN108530359A (zh) * | 2017-03-01 | 2018-09-14 | 浙江京新药业股份有限公司 | 一种伊伐布雷定杂质的制备方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1140049A (en) * | 1965-04-02 | 1969-01-15 | Alphachimie S A | N-substituted tetrahydrobenzazepines |
US3743731A (en) * | 1971-03-16 | 1973-07-03 | Schering Corp | Substituted benzazepines for producing skeletal muscle relaxation |
DE3119874A1 (de) * | 1981-05-19 | 1982-12-09 | Dr. Karl Thomae Gmbh, 7950 Biberach | "benzazepinderivate, ihre herstellung und ihre verwendung als arzneimittel" |
FR2681862B1 (fr) * | 1991-09-27 | 1993-11-12 | Adir Cie | Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent. |
FR2868777B1 (fr) * | 2004-04-13 | 2006-05-26 | Servier Lab | Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable |
FR2870537A1 (fr) * | 2004-05-19 | 2005-11-25 | Servier Lab | Nouveau procede de synthese du (1s)-4,5-dimethoxy-1-(methyl aminomethyl-)-benzocyclobutane et de ses sels d'addition, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable |
EP2097383B1 (en) * | 2006-11-30 | 2012-02-08 | Cadila Healthcare Limited | Process for preparation of ivabradine hydrochloride |
CN101284813B (zh) * | 2007-04-12 | 2012-08-15 | 上海优拓医药科技有限公司 | 伊伐布雷定的制备方法 |
PT2471780E (pt) | 2007-05-30 | 2015-02-24 | Ind Swift Lab Ltd | Sais oxalato de ivabradina cristalinos e seus polimorfos |
-
2009
- 2009-03-31 ME MEP-2010-55A patent/ME00987B/me unknown
- 2009-03-31 FR FR0901555A patent/FR2943667B1/fr not_active Expired - Fee Related
-
2010
- 2010-03-16 SG SG201001800-0A patent/SG165254A1/en unknown
- 2010-03-16 PE PE2010000154A patent/PE20100714A1/es not_active Application Discontinuation
- 2010-03-17 MY MYPI2010001176A patent/MY145611A/en unknown
- 2010-03-17 UY UY0001032500A patent/UY32500A/es not_active Application Discontinuation
- 2010-03-18 AU AU2010201058A patent/AU2010201058B2/en not_active Ceased
- 2010-03-18 MA MA32704A patent/MA31745B1/fr unknown
- 2010-03-22 CL CL2010000254A patent/CL2010000254A1/es unknown
- 2010-03-23 MX MX2010003184A patent/MX2010003184A/es active IP Right Grant
- 2010-03-24 CA CA2697562A patent/CA2697562C/fr not_active Expired - Fee Related
- 2010-03-25 ZA ZA2010/02121A patent/ZA201002121B/en unknown
- 2010-03-29 GE GEAP201011741A patent/GEP20125460B/en unknown
- 2010-03-29 AR ARP100101002A patent/AR075977A1/es not_active Application Discontinuation
- 2010-03-29 UA UAA201003588A patent/UA102232C2/ru unknown
- 2010-03-29 TW TW099109451A patent/TWI419879B/zh not_active IP Right Cessation
- 2010-03-29 SA SA110310240A patent/SA110310240B1/ar unknown
- 2010-03-29 NZ NZ584309A patent/NZ584309A/en not_active IP Right Cessation
- 2010-03-29 US US12/798,042 patent/US8101747B2/en not_active Expired - Fee Related
- 2010-03-30 AT AT10290166T patent/ATE523494T1/de active
- 2010-03-30 EA EA201000397A patent/EA016335B1/ru not_active IP Right Cessation
- 2010-03-30 PL PL10290166T patent/PL2241554T3/pl unknown
- 2010-03-30 SI SI201030013T patent/SI2241554T1/sl unknown
- 2010-03-30 WO PCT/FR2010/000268 patent/WO2010112704A1/fr active Application Filing
- 2010-03-30 DK DK10290166.7T patent/DK2241554T3/da active
- 2010-03-30 ES ES10290166T patent/ES2373369T3/es active Active
- 2010-03-30 RS RS20110479A patent/RS51962B/en unknown
- 2010-03-30 EP EP10290166A patent/EP2241554B1/fr active Active
- 2010-03-30 JP JP2010076768A patent/JP5107382B2/ja active Active
- 2010-03-30 BR BRPI1000735-0A patent/BRPI1000735A2/pt not_active Application Discontinuation
- 2010-03-30 PT PT10290166T patent/PT2241554E/pt unknown
- 2010-03-31 CN CN201210034916.XA patent/CN102603634B/zh not_active Expired - Fee Related
- 2010-03-31 KR KR1020100029258A patent/KR101166630B1/ko active IP Right Grant
- 2010-03-31 CN CN2010101547205A patent/CN101851205B/zh not_active Expired - Fee Related
- 2010-03-31 JO JO2010104A patent/JO2782B1/en active
-
2011
- 2011-03-28 HK HK11103103.5A patent/HK1148748A1/xx not_active IP Right Cessation
- 2011-12-05 CY CY20111101203T patent/CY1112136T1/el unknown
- 2011-12-06 HR HR20110915T patent/HRP20110915T1/hr unknown
-
2012
- 2012-10-24 HK HK12110572.1A patent/HK1169827A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200901563A1 (ru) | Новый способ синтеза ивабрадина и его солей присоединения с фармацевтически приемлемой кислотой | |
EA201101147A1 (ru) | Новый способ синтеза ивабрадина и его солей присоединения с фармацевтически приемлемой кислотой | |
EA201000398A1 (ru) | Новый способ синтеза ивабрадина и его солей присоединения с фармацевтически приемлемой кислотой | |
EA201200498A1 (ru) | Новый способ синтеза ивабрадина и его фармацевтически приемлемых кислотно-аддитивных солей | |
EA201000397A1 (ru) | Новый способ синтеза ивабрадина и его солей присоединения с фармацевтически приемлемой кислотой | |
EA201200123A1 (ru) | Новый способ синтеза ивабрадина и его фармацевтически приемлемых кислотно-аддитивных солей | |
EA201100230A1 (ru) | Новый способ синтеза ивабрадина и его аддитивных солей с фармацевтически приемлемой кислотой | |
EA201201385A1 (ru) | Новый способ синтеза ивабрадина и его фармацевтически приемлемых кислотно-аддитивных солей | |
EA201301136A2 (ru) | Новый способ синтеза (2e)-3-(3,4-диметоксифенил)проп-2-еннитрила, применение в синтезе ивабрадина и его фармацевтически приемлемых кислотно-аддитивных солей | |
EA201301235A1 (ru) | Новый способ синтеза 3-(2-бром-4,5-диметоксифенил)пропаннитрила и применение в синтезе ивабрадина и его фармацевтически приемлемых кислотно-аддитивных солей | |
EA201400473A1 (ru) | Способ синтеза 3,4-диметоксибицикло[4.2.0]окта-1,3,5-триен-7-карбонитрила и применение для синтеза ивабрадина и его солей присоединения с фармацевтически приемлемой кислотой | |
EA201300281A2 (ru) | Новый способ синтеза ивабрадина и его аддитивных солей с фармацевтически приемлемой кислотой | |
EA201201571A1 (ru) | Новый способ синтеза ивабрадина и его фармацевтически приемлемых кислотно-аддитивных солей | |
EA201301020A1 (ru) | Новый способ синтеза 3-(2-бром-4,5-диметоксифенил)пропаннитрила и применение в синтезе ивабрадина и его фармацевтически приемлемых кислотно-аддитивных солей | |
SG165255A1 (en) | New process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG MD TJ TM RU |